Atra stock forecast.

16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.LVTX Stock 12 Months Forecast. $6.00. (354.55% Upside) Based on 3 Wall Street analysts offering 12 month price targets for LAVA Therapeutics in the last 3 months. The average price target is $6.00 with a high forecast of $6.00 and a low forecast of $6.00. The average price target represents a 354.55% change from the last price of $1.32.What's Happening With Atara Biotherapeutics Inc Stock Today? Atara Biotherapeutics Inc (ATRA) stock is trading at $0.65 as of 1:00 PM on Friday, Nov 24, a gain of $0.08, or 13.93% from the previous closing price of $0.57. The stock has traded between $0.55 and $0.72 so far today. Volume today is 7,132,201 compared to average volume of 6,444,546.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median ... Sep 19, 2023 · Atara Biotherapeutics Inc (ATRA) stock experienced a significant surge today following the release of optimistic price forecasts from analysts. With a median target of $20.00, the stock is expected to witness a staggering 1,165.82% increase from its last closing price of $1.58.

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median ...In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.

Atara Biotherapeutics stock forecast for 18.11.2023. Estimated Average Forecasted Atara Biotherapeutics Price: 1.92 Positive intraday dynamics of the instrument is expected with 2.384% volatility is expected. Pessimistic forecast: 1.89. Optimistic: 1.93. Atara Biotherapeutics stock forecast for 19.11.2023.

7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.9 nov 2023 ... ATRA stock had an impressive performance on November 9, 2023. The stock experienced a significant increase in its target price, with ...Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.

8 brokers have issued 12-month target prices for Cresco Labs' stock. Their CRLBF share price targets range from $2.50 to $34.00. On average, they predict the company's stock price to reach $16.05 in the next twelve months. This suggests a possible upside of 833.1% from the stock's current price. View analysts price targets for CRLBF …

The Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ...

It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecastsP.O. Box 505000. Louisville, KY 40233. T: (781) 575-2879. [email protected]. Atara is harnessing the natural power of the immune system to develop off-the-shelf cell therapies for difficult-to-treat cancers and autoimmune conditions, including multiple sclerosis, that can be rapidly delivered to patients within …Nov 27, 2023 · Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low. We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.Find real-time BLRX - BioLine RX Ltd stock quotes, company profile, news and forecasts from CNN Business.S Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for SentinelOne in the last 3 months. The average price target is $18.97 with a high forecast of $23.00 and a low forecast of $16.50. The average price target represents a 5.86% change from the last price of $17.92.

ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period. When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.Price Prediction forecast forAtara Biotherapeutics to November 28, and an in-depth analysis for the week of 26 November to 2 December. Monthly forecasts ATRA for 2023 with target levels, support & resistance insights to make informed investment decisions.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts.The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million.

Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of …This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories. …Find the latest Astra Space, Inc. (ASTR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...Detailed statistics for Atara Biotherapeutics, Inc. (ATRA) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast ...allforecast.comATRA Earnings Date and Information. Atara Biotherapeutics last posted its earnings data on November 1st, 2023. The biotechnology company reported ($0.66) EPS for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The company had revenue of $2.14 million for the quarter, compared to analysts' expectations of $2.20 million.

We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.

All stock predictions. Overall outlook for Atara Biotherapeutics stock. 2023. 2024. ... (ATRA) stock consensus forecasts for 2023. Last update: 09/29/2023, 04:22 AM ...

Nov 27, 2023 · Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $14.72 target price for Atara Biotherapeutics stock stock. Today 200 Day Moving Average is the resistance level (2.683 $). Nov 13, 2023 · Atara Biotherapeutics stock price predictions for 2022 using artificial intelligence. How much will Atara Biotherapeutics stock be worth in 2022? Target price in 2022. 13 brokerages have issued twelve-month price targets for Royal Bank of Canada's stock. Their RY share price targets range from C$122.00 to C$142.00. On average, they predict the company's share price to reach C$133.21 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Aug 21, 2023 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%. Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —. The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingDec 2022 , the consensus EPS* forecast has ...The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...Atara Biotherapeutics Stock Forecast. Is Atara Biotherapeutics Stock Undervalued? The current Atara Biotherapeutics [ ATRA] share price is $0.65. The Score for ATRA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal. ATRA is currently trading in the 10-20% percentile range relative to its historical ...Tata Motors Ltd. () Stock Market info Recommendations: Buy or sell Tata Motors stock? Mumbai Stock Market & Finance report, prediction for the future: You'll find the Tata Motors share forecasts, stock quote and buy / sell signals below.According to present data Tata Motors's Tata Motors Ltd shares and potentially its market environment have been in a …Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.The current average ATRA price target, as estimated by these analysts, is $3.00. The predictions for the future ATRA stock price range from a low of $3.00 to a high of $3.00, highlighting the variability of market expectations for ATRA. Instagram:https://instagram. stock price bbbyphilips n.v.foxstocknextera stocks Should You Buy or Sell Arrival Stock? Get The Latest ARVL Stock Analysis, Price Target, Headlines, Short Interest at MarketBeat. ... View our ARVL earnings forecast. When did Arrival's stock split? Arrival shares reverse split before market open on Friday, April 14th 2023. The 1-50 reverse split was announced on Friday, April 14th 2023. aaa stockwallstreet weekend Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights. sell xbox 360 games for cash The Trade Desk, Inc. (NASDAQ:TTD) issued its quarterly earnings data on Thursday, November, 9th. The technology company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.05. The technology company had revenue of $493.27 million for the quarter, compared to the consensus estimate of ...The ATRA stock price is -767.69% off its 52-week high price of $5.64 and 69.23% above the 52-week low of $0.20. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.67 million shares traded. The 3-month trading volume is 3.89 million shares. The consensus among analysts is that Atara Biotherapeutics Inc ...